Condition
Nephropathy clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Nephropathy clinical trials that are recruiting, at sites in 5 countries (most in China (2), United States (2), France (1)). By phase: Early Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 5Countries
Newest Nephropathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BK virus in kidney transplant patients and donors: who carries the virus and why | — | Grenoble | Recruiting | Jan 16, 2026 |
| Diabetes Complications in People with Cystic Fibrosis-Related Diabetes (SPeCTRuM) | — | Birmingham, Alabama and 17 other locations | Recruiting | Feb 20, 2025 |
| Using anti-CD19 CAR NK cells to treat immune nephropathy | Early Phase 1 | Shanghai | Recruiting | Jun 21, 2024 |
| Investigating kidney cell regeneration in nephropathy | — | Florence | Recruiting | Mar 22, 2024 |
| Huaier granule treatment for idiopathic membranous nephropathy | Phase 4 | Beijing, Beijing Municipality | Recruiting | May 3, 2023 |
| Genetic testing for kidney disease risk in African Americans | — | St Louis, Missouri | Recruiting | Dec 19, 2022 |
| Understanding kidney issues in adolescents with type 2 diabetes | — | Winnipeg, Manitoba | Recruiting | Jun 29, 2016 |
All recruiting trials (7)
-
BK virus in kidney transplant patients and donors: who carries the virus and why
This study tests BK virus in kidney transplant recipients and their donors to see where the virus comes from and how the immune system responds.
-
Diabetes Complications in People with Cystic Fibrosis-Related Diabetes (SPeCTRuM)
This project will see how common diabetes-related complications (like eye, nerve, and blood vessel problems) are in adolescents and adults living with cystic fibrosis-related diabetes.
-
Using anti-CD19 CAR NK cells to treat immune nephropathy
This study is testing if a new type of cell therapy can help people with tough-to-treat immune nephropathy feel better and improve their kidney function.
-
Investigating kidney cell regeneration in nephropathy
This study is testing how certain kidney cells can help repair damage in people with kidney disease and acute kidney injury.
-
Huaier granule treatment for idiopathic membranous nephropathy
This study is testing if Huaier granules can be a safe and effective treatment for people with idiopathic membranous nephropathy who haven't responded well to standard medications.
-
Genetic testing for kidney disease risk in African Americans
This study is trying to see if knowing about certain genetic risks for kidney disease helps African Americans with high blood pressure take better care of their health.
-
Understanding kidney issues in adolescents with type 2 diabetes
This study is trying to find out what biological, psychological, and social factors might be causing kidney problems in teenagers with type 2 diabetes.
Related topics
Quick answers
How many Nephropathy clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (2 trials), United States (2 trials), France (1 trial), Canada (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.